197 related articles for article (PubMed ID: 36829085)
21. Initial Experience With Simultaneous 18F-FDG PET/MRI in the Evaluation of Cardiac Sarcoidosis and Myocarditis.
Hanneman K; Kadoch M; Guo HH; Jamali M; Quon A; Iagaru A; Herfkens R
Clin Nucl Med; 2017 Jul; 42(7):e328-e334. PubMed ID: 28418949
[TBL] [Abstract][Full Text] [Related]
22. Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol.
Christopoulos G; Jouni H; Acharya GA; Blauwet LA; Kapa S; Bois J; Chareonthaitawee P; Rodriguez-Porcel MG
J Nucl Cardiol; 2021 Apr; 28(2):661-671. PubMed ID: 31111450
[TBL] [Abstract][Full Text] [Related]
23. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis.
Sobic-Saranovic D; Grozdic I; Videnovic-Ivanov J; Vucinic-Mihailovic V; Artiko V; Saranovic D; Djuric-Stefanovic A; Masulovic D; Odalovic S; Ilic-Dudvarski A; Popevic S; Pavlovic S; Obradovic V
J Nucl Med; 2012 Oct; 53(10):1543-9. PubMed ID: 22879080
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of myocardial washout of
Suzuki M; Izawa Y; Fujita H; Miwa K; Takahashi Y; Toh H; Toba T; Fujiwara S; Hashimura H; Kono AK; Hirata KI
Ann Nucl Med; 2022 Jun; 36(6):544-552. PubMed ID: 35303274
[TBL] [Abstract][Full Text] [Related]
25. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
Lu Y; Grant C; Xie K; Sweiss NJ
Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
[TBL] [Abstract][Full Text] [Related]
26. Assessment of Cardiac Sarcoidosis: FDG PET and BMIPP SPECT.
Campisi R; Merani MF; Rodríguez MI
Curr Cardiol Rep; 2022 Dec; 24(12):1873-1882. PubMed ID: 36282434
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic Performance of
Rubini G; Ferrari C; Altini C; Cimino A; Fanelli M; Niccoli Asabella A
Curr Med Imaging Rev; 2019; 15(1):32-38. PubMed ID: 31964325
[TBL] [Abstract][Full Text] [Related]
28. Positron emission tomography in clinically suspected myocarditis - STREAM study design.
Ozierański K; Tymińska A; Kobylecka M; Caforio ALP; Šobić-Šaranović D; Ristić AD; Maksimović R; Seferović PM; Marcolongo R; Królicki L; Opolski G; Grabowski M
Int J Cardiol; 2021 Jun; 332():113-118. PubMed ID: 33657398
[TBL] [Abstract][Full Text] [Related]
29. FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis.
Lucinian YA; Martineau P; Poenaru R; Tremblay-Gravel M; Cadrin-Tourigny J; Harel F; Pelletier-Galarneau M
J Nucl Cardiol; 2023 Dec; 30(6):2490-2500. PubMed ID: 37258950
[TBL] [Abstract][Full Text] [Related]
30. FDG PET imaging in sarcoidosis.
Sobic-Saranovic D; Artiko V; Obradovic V
Semin Nucl Med; 2013 Nov; 43(6):404-11. PubMed ID: 24094707
[TBL] [Abstract][Full Text] [Related]
31. The Utility of
Chen H; Jin R; Wang Y; Li L; Li K; He Y
Biomed Res Int; 2018; 2018():1823710. PubMed ID: 29686996
[TBL] [Abstract][Full Text] [Related]
32. 18-FDG-PET in a patient cohort suspected for cardiac sarcoidosis: Right ventricular uptake is associated with pathological uptake in mediastinal lymph nodes.
Tuominen H; Haarala A; Tikkakoski A; Kähönen M; Nikus K; Sipilä K
J Nucl Cardiol; 2020 Feb; 27(1):109-117. PubMed ID: 29721764
[TBL] [Abstract][Full Text] [Related]
33. [
Borges-Rosa J; Oliveira-Santos M; Silva R; Gomes A; de Almeida J; Costa G; Gonçalves L; Ferreira MJ
Int J Cardiol; 2022 Jan; 347():38-43. PubMed ID: 34736982
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.
Okumura W; Iwasaki T; Toyama T; Iso T; Arai M; Oriuchi N; Endo K; Yokoyama T; Suzuki T; Kurabayashi M
J Nucl Med; 2004 Dec; 45(12):1989-98. PubMed ID: 15585472
[TBL] [Abstract][Full Text] [Related]
35. Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR?
Chen W; Jeudy J
Curr Cardiol Rep; 2019 Jun; 21(8):76. PubMed ID: 31243587
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of
Protonotarios A; Wicks E; Ashworth M; Stephenson E; Guttmann O; Savvatis K; Sekhri N; Mohiddin SA; Syrris P; Menezes L; Elliott P
Int J Cardiol; 2019 Jun; 284():99-104. PubMed ID: 30409737
[TBL] [Abstract][Full Text] [Related]
37. Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review.
Treglia G; Taralli S; Giordano A
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):87-94. PubMed ID: 22117499
[TBL] [Abstract][Full Text] [Related]
38. Features and clinical impact of extra-cardiac lesions with
Higashi H; Inaba S; Iio C; Inoue K; Ogimoto A; Miyagawa M; Mochizuki T; Ikeda S; Yamaguchi O
Int J Cardiol Heart Vasc; 2020 Oct; 30():100587. PubMed ID: 32743044
[TBL] [Abstract][Full Text] [Related]
39. Intraocular sarcoidosis: association of clinical characteristics of uveitis with findings from 18F-labelled fluorodeoxyglucose positron emission tomography.
Rahmi A; Deshayes E; Maucort-Boulch D; Varron L; Grange JD; Kodjikian L; Seve P
Br J Ophthalmol; 2012 Jan; 96(1):99-103. PubMed ID: 21464036
[TBL] [Abstract][Full Text] [Related]
40. Muscular sarcoidosis in the eyes of
Milojevic IG; Sobic-Saranovic D; Milojevic B; Artiko VM
J Clin Ultrasound; 2022 Mar; 50(3):399-404. PubMed ID: 34951698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
